Nisa Investment Advisors’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
SAM
Nisa Investment Advisors's PRAX Position: Q2 2026 in Review
Nisa Investment Advisors reduced its Praxis Precision Medicines (PRAX) stake by 2.7% in Q2 2026, selling an estimated $53.5K and leaving 6,111 shares worth $2.05M. The position accounts for 0.01% of the portfolio, ranked #616.
Nisa Investment Advisors first reported a position in PRAX in Q4 2021 and has held it in 12 quarters since. The position peaked at $2.29M in Q4 2025. 93 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.
- Nisa Investment Advisors held 6,111 shares of Praxis Precision Medicines worth $2.05M as of Q2 2026.
- Nisa Investment Advisors sold 169 Praxis Precision Medicines shares in Q2 2026, an estimated $53.5K.
- Praxis Precision Medicines made up 0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #616 holding.
- Nisa Investment Advisors first reported a position in Praxis Precision Medicines in Q4 2021 and has held it in 12 quarters since.
- Nisa Investment Advisors's Praxis Precision Medicines position peaked at $2.29M in Q4 2025.
- 93 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.
Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.